NCT06737211

Brief Summary

Major surgical operations of the gastrointestinal tract, such as colorectal resections due to several diseases, lead to significant burden on the human body, which is expressed during the first postoperative hours with an intense inflammatory reaction and consumption of a large amount of energy, increasing nutritional requirements of the patients. Therefore, specific protocols have been implemented for the early initiation of oral feeding in patients undergoing colorectal resections. However, it is not feasible for every patient to meet them due to several reasons, such as old age and associated pathophysiological changes, use of opioid drugs for the management of postoperative pain, which is associated with postoperative ileus or nausea, as well as open resection which lead to gastrointestinal impairment during the first postoperative days. The energy deficit that occurs during the early postoperative period, which appears to be associated with adverse clinical outcomes, can be counterbalanced by the administration of parenteral nutrition. However, the conventional way of administration through central venous lines is associated with significant complications. For this reason, administration of parenteral nutrition through a peripheral venous catheter could be used alternatively, which avoids morbidity and has been also effective in maintaining the patients' energy balance, even during the first postoperative hours. Therefore, the main purpose of the present study is to investigate the efficacy of the administration of peripheral parenteral nutrition on the postoperative outcomes of patients undergoing colorectal resections. Moreover, the correlation of the administration of peripheral parenteral nutrition with the reaction to post-operative stress and with the nutritional status of the patients post-operatively, which are determining factors for the clinical course of these patients, will be investigated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P50-P75 for not_applicable colorectal-cancer

Timeline
Completed

Started Dec 2024

Shorter than P25 for not_applicable colorectal-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2024

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

December 7, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 17, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 20, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 20, 2025

Completed
Last Updated

January 6, 2026

Status Verified

December 1, 2024

Enrollment Period

9 months

First QC Date

December 7, 2024

Last Update Submit

January 3, 2026

Conditions

Keywords

peripheral parenteral nutritionpostoperative outcomescolorectal surgerycolorectal cancerinflammatory bowel diseasebowel ischemia

Outcome Measures

Primary Outcomes (1)

  • Postoperative Surgical Stress and Short-term Nutritional Status

    Serum nutritional markers and acute phase proteins indicating postoperative surgical stress response.

    5 postoperative days

Secondary Outcomes (6)

  • Postoperative Morbidity

    90 postoperative days

  • Nasogastric tube removal

    30 postoperative days

  • Feeding start

    30 postoperative days

  • Early mobilization

    30 postoperative days

  • Opioid sparing analgesia

    30 postoperative days

  • +1 more secondary outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

2000 mL of peripheral parenteral nutrition with electrolytes (20 mL 7.45% KCl, 10 mL 20% MgSO4 and 20 mL 8.7% Na3PO4) will be administered via a peripheral venous catheter with a rhythm of 80cc/h from the time they will leave the operation room and will be transferred to the ward or the critical care unit (CCU) until the 5th postoperative day

Dietary Supplement: Peripheral Parenteral Nutrition

Control

NO INTERVENTION

1000 mL of 10% glucose saline with electrolytes (20 mL 7.45% KCl, 10 mL 20% MgSO4 and 20 mL 8.7% Na3PO4) will be administered via a central or peripheral venous catheter with a rhythm of 80cc/h until the 5th postoperative day

Interventions

2000 mL of peripheral parenteral nutrition with electrolytes (20 mL 7.45% KCl, 10 mL 20% MgSO4 and 20 mL 8.7% Na3PO4) will be administered via a peripheral venous catheter with a rhythm of 80cc/h from the time they will leave the operation room and will be transferred to the ward or the critical care unit (CCU) until the 5th postoperative day

Intervention

Eligibility Criteria

Age18 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Colorectal resection surgery
  • Open or laparoscopic procedures
  • Anastomosis, end-stoma or defunctioning stoma formation after colorectal resection
  • Elective or emergent procedures
  • Diagnosis of colorectal cancer, inflammatory bowel disease, diverticular disease and bowel ischemia
  • Small bowel resection combined with colorectal resection
  • Age \> 18 years old
  • Informed consent

You may not qualify if:

  • Small bowel resection without colorectal resection
  • End-stoma or defunctioning stoma formation without colorectal resection
  • Preoperative parenteral nutrition administration
  • Administration of parenteral nutrition after the 4th postoperative day
  • Peripheral parenteral nutrition initiation after the 1st postoperative day
  • Contraindication for peripheral parenteral nutrition administration
  • Age \< 18 years old
  • No informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hippocration General Hospital of Athens

Athens, Greece

Location

Related Publications (5)

  • Studer P, Raber G, Ott D, Candinas D, Schnuriger B. Risk factors for fatal outcome in surgical patients with postoperative aspiration pneumonia. Int J Surg. 2016 Mar;27:21-25. doi: 10.1016/j.ijsu.2016.01.043. Epub 2016 Jan 20.

    PMID: 26804349BACKGROUND
  • Herbert G, Perry R, Andersen HK, Atkinson C, Penfold C, Lewis SJ, Ness AR, Thomas S. Early enteral nutrition within 24 hours of lower gastrointestinal surgery versus later commencement for length of hospital stay and postoperative complications. Cochrane Database Syst Rev. 2019 Jul 22;7(7):CD004080. doi: 10.1002/14651858.CD004080.pub4.

    PMID: 31329285BACKGROUND
  • Shin CH, Long DR, McLean D, Grabitz SD, Ladha K, Timm FP, Thevathasan T, Pieretti A, Ferrone C, Hoeft A, Scheeren TWL, Thompson BT, Kurth T, Eikermann M. Effects of Intraoperative Fluid Management on Postoperative Outcomes: A Hospital Registry Study. Ann Surg. 2018 Jun;267(6):1084-1092. doi: 10.1097/SLA.0000000000002220.

    PMID: 28288059BACKGROUND
  • Cardinale F, Chinellato I, Caimmi S, Peroni DG, Franceschini F, Miraglia Del Giudice M, Bernardini R. Perioperative period: immunological modifications. Int J Immunopathol Pharmacol. 2011 Jul-Sep;24(3 Suppl):S3-12. doi: 10.1177/03946320110240s302.

    PMID: 22014920BACKGROUND
  • Gillis C, Carli F. Promoting Perioperative Metabolic and Nutritional Care. Anesthesiology. 2015 Dec;123(6):1455-72. doi: 10.1097/ALN.0000000000000795.

    PMID: 26248016BACKGROUND

MeSH Terms

Conditions

Colorectal NeoplasmsInflammatory Bowel DiseasesMalnutritionHyperphagia

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesGastroenteritisNutrition DisordersNutritional and Metabolic DiseasesSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 7, 2024

First Posted

December 17, 2024

Study Start

December 1, 2024

Primary Completion

August 20, 2025

Study Completion

November 20, 2025

Last Updated

January 6, 2026

Record last verified: 2024-12

Locations